Home  >  Products  >  CDKN3 (cyclin-dependent kinase inhibitor 3 (CDK2-associated dual specificity phosphatase)) Blocking Peptide (100ug)
CDKN3 (cyclin-dependent kinase inhibitor 3 (CDK2-associated dual specificity phosphatase)) Blocking Peptide (100ug)

CDKN3 (cyclin-dependent kinase inhibitor 3 (CDK2-associated dual specificity phosphatase)) Blocking Peptide (100ug)


Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-CDKN3 antibody (Catalogue #: ARP53629_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP53629
Size: 100 ug
Weight: 23kDa
Gene: 1033
Format: Lyophilized powder
Target: CDKN3 belongs to the dual specificity protein phosphatase family. It was identified as a cyclin-dependent kinase inhibitor, and has been shown to interact with, and dephosphorylate CDK2 kinase, thus prevent the activation of CDK2 kinase. This gene was reported to be deleted, mutated, or overexpressed in several kinds of cancers. The protein encoded by this gene belongs to the dual specificity protein phosphatase family. It was identified as a cyclin-dependent kinase inhibitor, and has been shown to interact with, and dephosphorylate CDK2 kinase, thus prevent the activation of CDK2 kinase. This gene was reported to be deleted, mutated, or overexpressed in several kinds of cancers. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.
Alternative names: CDI1; CIP2; FLJ25787; KAP; KAP1; MGC70625